Contineum Therapeutics • CTNM
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need.
Ratings
3 / 5
1 rating in the last 12 months
5
4
3
2
1
$545.8M
Market Cap • 25/07/20242009
(há 15 anos)
2024
IPONASDAQ
Listagem
San Diego
Sede • CaliforniaValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CTNMSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.